Articles/ Brexit/ Pharma Market Access/ R&D/ UK & Europe/ Views and analysis Getting it right: the UK’s pathway for 2017 Linda Banks Brexit, European Patent Convention, HTA, market access, NICE, quintilesIMS, UK 0 Comment The implications for global pharma HQs and what the UK needs to do. Share X Getting it right: the UK’s pathway for 2017 https://pharmaphorum.com/views-and-analysis/getting-right-uks-pathway-2017/